Chen Zhao, M.D.
National Cancer Institute (NCI) · National Heart, Lung, and Blood Institute (NHLBI)
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Chen Zhao, M.D. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:35 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT05777603 · Study of Aerosolized Antibiotics and Pembrolizumab in Advanced Non-small Cell Lung CancerNational Cancer Institute (NCI) · recruiting · Advanced Non Small Cell Lung Cancer · principal investigator
- Ph2NCT05286827 · Olaparib in Subjects With Advanced Pancreatic Acinar Cell CarcinomaNational Cancer Institute (NCI) · terminated · Pancreatic Acinar Cell Carcinoma · principal investigator
- Ph2NCT04896073 · Superenhancer Inhibitor Minnelide in Advanced Refractory Adenosquamous Carcinoma of the Pancreas (ASCP)National Cancer Institute (NCI) · completed · Adenosquamous Carcinoma of the Pancreas · principal investigator
- Ph1NCT01445561 · Ultra Low Dose Interleukin-2 in Healthy VolunteersNational Heart, Lung, and Blood Institute (NHLBI) · completed · Hematologic Diseases · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:35 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in pancreatic cancer.